Effects of maternal protein restriction on central and peripheral renin-angiotensin systems in male rat offspring

Monique Assis de Vasconcelos Barros1, José Luiz de Brito Alves2, Rayssa Gabriella Nery Barros3

  • 1Laboratory of Nutrition, Physical Activity and Phenotypic Plasticity, Academic Center of Vitoria (CAV), Federal University of Pernambuco, 55608-680 Vitória de Santo Antão, Brazil; Graduate Program in Nutrition, Health Sciences Center, Federal University of Pernambuco, UFPE, 50670-901, Recife, Brazil; Carmen (Cardiology, Metabolism and Nutrition) Laboratory, INSERM U1060, Lyon-1 University, South Lyon Medical Faculty, 69921 Oullins, France.

Life Sciences
|October 13, 2020
PubMed

Insights

Maternal low-protein diet induces arterial hypertension in male offspring rats. The renin-angiotensin system (RAS) contributes peripherally, not centrally, to this condition, impacting cardiorespiratory control.

Area of Science:

  • Cardiovascular Physiology
  • Developmental Biology
  • Nutritional Science

Background:

  • Maternal dietary protein intake critically influences offspring development and long-term health.
  • The renin-angiotensin system (RAS) plays a key role in regulating blood pressure and cardiovascular function.
  • Nutritional programming during gestation can lead to persistent alterations in offspring physiology.

Purpose of the Study:

  • To investigate the role of the renin-angiotensin system (RAS) in cardiorespiratory control of male offspring from dams fed a low-protein diet.
  • To determine whether central or peripheral RAS activation contributes to hypertension in offspring exposed to maternal protein restriction.

Main Methods:

  • Male offspring from normoprotein (NP) and low-protein (LP) diet dams were studied.
  • Arterial pressure (AP), heart rate (HR), and respiratory frequency (RF) were measured at rest and after central (ICV) or peripheral (IV) administration of losartan.
  • Cardiovascular variability, peripheral chemoreflex sensitivity, and gene expression (Rac1, MAPK) were assessed.

Main Results:

  • LP offspring exhibited higher mean AP and RF compared to NP offspring.
  • Central losartan administration did not normalize AP or RF in LP rats, while peripheral losartan caused a greater reduction in MAP in LP rats.
  • LP rats showed reduced gene expression of Rac1 and similar peripheral chemoreflex sensitivity compared to NP rats.

Conclusions:

  • The RAS is involved peripherally, not centrally, in maintaining elevated blood pressure in male offspring of protein-restricted dams.
  • Maternal protein restriction induces hypertension in offspring, mediated by peripheral RAS components.
  • These findings highlight the impact of maternal nutrition on offspring cardiovascular health via RAS pathways.
Abstract

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.2K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
717